Summary & Overview
CPT 3056F: Clinical Measure 3056F
CPT code 3056F is a CPT-coded clinical measure for which the source description provides no summary. As a CPT code, it is part of the Current Procedural Terminology system used nationally to standardize reporting of clinical services and performance measures. The code’s presence in billing and quality workflows can influence claims processing, quality reporting, and administrative documentation across payers.
Key payers considered in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of what the code represents given available information, along with an outline of typical areas where such CPT measures matter: billing accuracy, quality measurement, and payer-specific claim adjudication. The publication flags missing input fields where relevant to guide further review.
This summary prepares clinicians, billing professionals, and policy analysts to identify gaps in documentation, to seek the detailed code descriptor from authoritative CPT sources, and to assess payer guidance once the full code definition is obtained. The content focuses on national implications for coding workflow and quality reporting rather than state-specific policy.
Billing Code Overview
CPT code 3056F has no summary available in the source description. Based on the code label, this entry represents a specific clinical or administrative measure captured within the CPT coding system.
-
Service type: Data not available in the input.
-
Typical site of service: Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult presenting to an otolaryngology or allergy clinic with chronic nasal obstruction, recurrent sinusitis, or nasal polyp disease causing persistent symptoms despite medical therapy. The clinician performs an in‑office nasal endoscopic assessment and documents findings such as polyp burden, mucosal edema, septal deviation, or obstructive inferior turbinate hypertrophy. The procedure associated with 3056F is performed in an ambulatory office or outpatient clinic setting under local anesthesia with topical decongestant and anesthetic agents. The workflow includes pre‑procedure counseling and consent, focused nasal endoscopy, targeted intervention (for example, biopsy, aspiration, debridement, or application of topical therapy), and brief post‑procedure observation. Typical documentation includes indication, informed consent, procedure performed, anesthesia used, findings, specimens sent (if any), complications (none expected), and post‑procedure instructions and follow‑up planning.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service on the same day | When an E/M visit is performed and documented as distinct from the procedure on the same day |